Dare Bioscience, Inc. — Director's Dealing 2015

May 29, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-05-27

Reporting Person: BELOFF GREGG (Interim CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-27	Stock Option (right to buy)	$5.89	A	90000	Acquired	2025-05-26	Common Stock (90000)	Direct

Footnotes

F1: This option was granted on May 27, 2015. The option vests in twelve equal monthly installments over the one year period following the date of grant.